Calliditas Therapeutics Stock (NASDAQ: CALT) stock price, news, charts, stock research, profile.
Open | $39.22 |
Close | $38.84 |
Volume / Avg. | 5.44K / 13.73K |
Day Range | 38.54 - 39.48 |
52 Wk Range | 15.25 - 41.90 |
Market Cap | $1.03B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calliditas Therapeutics (NASDAQ:CALT) through any online brokerage.
Other companies in Calliditas Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP) and Phibro Animal Health (NASDAQ:PAHC).
There is no analysis for Calliditas Therapeutics.
Calliditas Therapeutics has a consensus price target of $37.50.
The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $38.84 last updated July 17, 2024 at 3:30 PM EDT.
There are no upcoming dividends for Calliditas Therapeutics.
Calliditas Therapeutics’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Calliditas Therapeutics.
Calliditas Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.